The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) |
93.866 |
RFA-AG-19-021 |
| Innovative Technologies to Non-Invasively Monitor Genome Edited Cells In Vivo (UH2/UH3 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-18-025 |
| Expanding the Human Genome Engineering Repertoire (U01 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-18-024 |
| Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R01 - Clinical Trial Not Allowed) |
93.121, 93.307 |
PAR-18-875 |
| Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-18-023 |
| Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed) |
93.121, 93.307 |
PA-18-874 |
| Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-18-012 |
| Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Genome Editing (U01 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-18-022 |
| Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed) |
93.121, 93.279, 93.321, 93.393, 93.396, 93.846 |
PA-18-876 |
| Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed) |
93.084, 93.855 |
PA-18-872 |
| HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-18-029 |
| Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed) |
93.084, 93.855 |
PA-18-873 |
| BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR) (R41/R42 - Clinical Trials Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.867 |
PA-18-870 |
| BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 - Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.867 |
PA-18-871 |
| Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) |
93.393, 93.399 |
PAR-18-869 |
| Research Innovations for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (R61/R33 Clinical Trial Not Allowed) |
93.846 |
RFA-AR-19-012 |
| Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed) |
93.172 |
PA-18-868 |
| Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed) |
93.172 |
PA-18-867 |
| Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-18-030 |
| Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed) |
93.846 |
PAR-18-866 |
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-18-021 |
| Research Innovations for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33 Clinical Trial Not Allowed) |
93.846 |
RFA-AR-19-013 |
| Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed) |
93.846 |
PAR-18-865 |
| Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21 - Clinical Trial Optional) |
93.273, 93.279 |
PA-18-862 |
| Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 - Clinical Trial Optional) |
93.273, 93.279 |
PA-18-861 |
| Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 - Clinical Trial Optional) |
93.273, 93.279 |
PA-18-863 |
| Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-19-026 |
| Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed) |
93.855 |
PAR-18-860 |
| NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed) |
93.867 |
PAR-18-864 |
| Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-19-025 |
| Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed) |
93.855 |
PA-18-858 |
| Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed) |
93.855 |
PA-18-859 |
| BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-19-147 |
| Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed) |
93.273, 93.307, 93.361, 93.393, 93.399, 93.847 |
PAR-18-857 |
| BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-19-145 |
| Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed) |
93.213, 93.273, 93.307, 93.393, 93.399, 93.847 |
PA-18-856 |
| BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-19-146 |
| Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) |
93.393, 93.399, 93.847, 93.865 |
PAR-18-854 |
| Encouraging Development of Novel Amelogenesis Models (UG3/UH3 Clinical Trial Not Allowed) |
93.121 |
RFA-DE-19-004 |
| Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed) |
93.865 |
PAR-18-853 |
Search Results 4161-4200 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
